NASDAQ NMS - GLOBAL MARKET · CELU
+3.45% · +$0.0400 · Vol 188.4K
Market closed · last close 4:00 PM ET · price as of 19:05:57 ET
Celularity Inc

Celularity Inc

Biotechnology
$1.31
Card
Relationship Map

Follow $CELU

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CELU by email

Veridion Score

BETALOW CONF · 6 of 6 factors measuredMethodology
CELU
Celularity Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · LOW confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CELU moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CELU catalysts
About Celularity Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
115
Country
US

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.28
Day high
$1.35
Day low
$1.22
Previous close
$1.27
52W high
$2.27
-42.12% from high
52W low
$0.5979
43% of range
Market cap
$37.9M
EPS
$-3.4700
Beta
3.10
Shares out
28.9M
Volume
188.4K
0.02× rel vol
Avg volume
8.2M
VWAP
$1.29
Price history computed in-house
1W
-6.16%
1M
+64.20%
3M
+87.74%
1Y
-40.82%
YTD
+18.36%
SMA 50 $1.01 · above
SMA 200 $1.12 · above
52W position 43%

CELU overview

Veridion Score
59
Registered · 2026-09-18
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CELU.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CELU Form 4 filings
Public disclosures

Congress activity in CELU

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CELU in the cached public ledger.

Federal contracts

CELU contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CELU in this window.
Lobbying spend

CELU lobbying filings, year to date.

Registered lobbying filings matched to Celularity Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CELU in this window.
Loading news for CELU
Analyst ratings
Sovereign unlock shows live analyst consensus for CELU.
Options
Sovereign unlock shows live options positioning for CELU.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.